Company Search:
Advanced Search
Sponsored Links
Xiamen Kingdomway Group Co Company Snapshot
Xiamen Kingdomway Group Co operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xiamen Kingdomway Group Co with three other companies in this sector in China: Fuan Pharmaceutical Group Co Ltd (2017 sales of 2.09 billion Chinese Renmimbi [US$312.62 million] of which 100% was Pharmaceutical Industry), Tianjin Tianyao Pharmaceutical, Ltd. (1.97 billion Chinese Renmimbi [US$294.81 million] ), and PKU HealthCare Corp Ltd (2.15 billion Chinese Renmimbi [US$320.86 million] of which 80% was Merchandise&Material Selling).

Sales Analysis. Xiamen Kingdomway Group Co reported sales of 2.08 billion Chinese Renmimbi (US$311.69 million) for the year ending December of 2017. This represents an increase of 25.4% versus 2016, when the company's sales were 1.66 billion Chinese Renmimbi. This was the fourth straight year of sales growth at Xiamen Kingdomway Group Co. Sales of Health saw an increase of 25.5% in 2017, from 1.65 billion Chinese Renmimbi to 2.07 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xiamen Kingdomway Group Co
  Stock Performance Chart for Xiamen Kingdomway Group Co
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 15.83
(Figures in Chinese Renmimbi)
1 Week 6.8%   13 Weeks 8.8%  
4 Weeks 29.0%   52 Weeks -7.8%  
Xiamen Kingdomway Group Co Key Data:
  Ticker: 002626 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 2,084,623,655
(Year Ending Jan 2018).
Employees: 1,837
  Currency: Chinese Renmimbi Market Cap: 9,758,908,904
  Fiscal Yr Ends: December Shares Outstanding: 616,481,927
  Share Type: A Gu Closely Held Shares: 413,878,845
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.